FT Logo (1).png
Field Trip Health Ltd. Schedules First Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, August 17, 2021 at 8:30 am ET
August 10, 2021 07:55 ET | Field Trip Health, Ltd.
TORONTO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
FT Logo (1).png
Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP
July 27, 2021 15:32 ET | Field Trip Health, Ltd.
TORONTO, July 27, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic...
FT Logo (1).png
Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol "FTRP"
July 23, 2021 07:50 ET | Field Trip Health, Ltd.
TORONTO, July 23, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic...
FT Logo (1).png
Field Trip Health Ltd. to Present at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
July 08, 2021 17:00 ET | Field Trip Health, Ltd.
TORONTO, July 08, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
FT Logo (1).png
Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results
June 24, 2021 17:05 ET | Field Trip Health, Ltd.
Field Trip completes FY2021 as the largest vertically integrated psychedelics company positioned to be a leader in the emerging industryContinues to leverage its early mover opportunity by investing...
FT Logo (1).png
Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call for Friday, June 25, 2021 At 8:00 am ET
June 17, 2021 07:30 ET | Field Trip Health, Ltd.
TORONTO, June 17, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
FT Logo (1).png
Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch for FT-104, Its Novel Psychedelic Compound
June 15, 2021 07:30 ET | Field Trip Health, Ltd.
TORONTO, June 15, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, today...
FT Logo (1).png
Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market
June 08, 2021 07:30 ET | Field Trip Health, Ltd.
TORONTO, June 08, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to...
FT Logo (1).png
Field Trip Health Ltd. to Commence Trading on the Toronto Stock Exchange on June 7, 2021
June 03, 2021 07:30 ET | Field Trip Health, Ltd.
TORONTO, June 03, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to...
FT Logo (1).png
Field Trip Health Ltd. Receives Conditional Approval to Up-List to the Toronto Stock Exchange
May 27, 2021 07:30 ET | Field Trip Health, Ltd.
TORONTO, May 27, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to...